Improving medication safety and diabetes management in Hong Kong: a multidisciplinary approach

Chung, Agnes Ys; Anand, Shweta; Wong, Ian C K; Tan, K. C. B.; Wong, Christine Ff; Chui, William; Chan, Esther W.

doi:10.12809/hkmj165014

Cited by 15 publications

(26 citation statements)

References 32 publications

Supporting

Mentioning

Contrasting

Unclassified

Order By: Relevance

“…In addition, the mean number of DTPs was 1.86 ± 0.53 per patient, which is in line with the studies by Ayele et al 36 (1.8), Koyra et al 15 (1.8 ± 0.75), and Huri and Wee 14 (1.9 ± 1.2). However, it is considerably higher than the finding conducted by Wong (0.9 ± 0.6), 37 Demoz et al 17 (1.16 ± 0.42), Nasution et al 38 (1.34), Shareef et al 39 (1.25), and Kumar et al 40 (1.45). On the contrary, the mean number of DTPs is lower than those studies conducted in Nigeria (2.1 ± 1.4), 41 Ethiopia (2.06 ± 0.861), 42 and Indonesia (2.88 ± 0.23).…”

Section: Discussionmentioning

confidence: 57%

Magnitude and determinants of drug therapy problems among type 2 diabetes mellitus patients with hypertension in Ethiopia

et al. 2020

View full text Add to dashboard Cite

Introduction: Type 2 diabetes mellitus patients with hypertension are at high risk of drug therapy problems since they are subject to receive multiple drug therapies due to comorbidities. Objectives: To determine the magnitude of drug therapy problems and its determinants among Type 2 diabetes mellitus patients with hypertension. Methods: A cross-sectional study was employed among 423 randomly selected participants based on the inclusion criteria. A structured questionnaire and review of patients’ medical record were employed in the data collection. The classification system used by Cipolle was used to classify and evaluate drug therapy problems. Data were analyzed using Statistical Package for the social sciences version 25.0 software. Multivariate logistic regression analysis was used to identify determinants of drug therapy problems with a statistical significance of p ⩽ 0.05. Results: A total of 491 drug therapy problems with a mean of 1.86 ± 0.53 drug therapy problems per patient were identified, and 62.4% (264) of them experienced at least one drug therapy problem. Non-compliance (197, 40.1%), needs of additional drug therapy (119, 24.2%), and dosage too low (91, 18.5%) were the most frequently observed drug therapy problems in the study setting. Anti-diabetic medications (88.4%), statins (44.5%), and aspirin (33.5%) were the most commonly involved drugs in drug therapy problems. The determinants of drug therapy problems were very low family income (adjusted odds ratio = 4.64, p = 0.010), age (45–65 years old) (adjusted odds ratio = 2.55, p = 0.008), presence of comorbidity (adjusted odds ratio = 9.19, p < 0.001), and taking ⩾5 medications (adjusted odds ratio = 2.84, p = 0.001). Conclusion: Approximately three out of five patients had one or more drug therapy problems encountered. In this study, the most common types of drug therapy problems were non-compliance, needs additional drug therapy, and dosage too low. Family monthly income, age, comorbidities, and number of medications were the significant determinants of drug therapy problems. Therefore, patient education regarding medication adherence, routine medication review, and strengthening clinical pharmacy services should be promoted.

show abstract

Section: Discussionmentioning

confidence: 57%

Magnitude and determinants of drug therapy problems among type 2 diabetes mellitus patients with hypertension in Ethiopia

et al. 2020

View full text Add to dashboard Cite

show abstract

“…Another local study has demonstrated a positive impact on medication safety in patients with diabetes by pharmacists' intervention in collaboration with a multidisciplinary team. 20 The feasibility of incorporating a pharmacist as part of a multidisciplinary team of health care professionals must be explored in geriatric wards in Hong Kong. With increasing life expectancy, the expanding elderly population will equate to an increase in morbidity and mortality owing to drug-related problems where the need for trained health care professionals to perform medication reviews will be in even greater demand.…”

Section: Discussionmentioning

confidence: 99%

Effectiveness of a pharmacist-led medication review programme on medication appropriateness and hospital readmissions among geriatric in-patients in Hong Kong

et al. 2018

View full text Add to dashboard Cite

show abstract

“…Unfortunately, little data are published with regard to pertinent multisystemic rare diseases, perhaps due to the barriers noted. However, improved patient outcomes due to a multidisciplinary approach have been observed in pediatric chronic kidney disease, sickle cell disease, recalcitrant aerodigestive complaints, and diabetes management, among others (Ajarmeh, Er, Brin, Djurdjev, & Dionne, ; Asare et al, ; Chung et al, ; Rotsides et al, ). Compared to a control group, a group of pediatric chronic kidney disease patients in British Columbia, Canada, showed improved outcomes, particularly in anemia management, bone mineral metabolism, nutrition, and renal disease progression.…”

Section: A Multidisciplinary Approachmentioning

confidence: 99%

A multidisciplinary approach to the clinical management of Prader–Willi syndrome

Duis

Wattum

Scheimann

et al. 2019

Molec Gen & Gen Med

View full text Add to dashboard Cite

Background Prader–Willi syndrome (PWS) is a complex neuroendocrine disorder affecting approximately 1/15,000–1/30,000 people. Unmet medical needs of individuals with PWS make it a rare disease that models the importance of multidisciplinary approaches to care with collaboration between academic centers, medical homes, industry, and parent organizations. Multidisciplinary clinics support comprehensive, patient‐centered care for individuals with complex genetic disorders and their families. Value comes from improved communication and focuses on quality family‐centered care. Methods Interviews with medical professionals, scientists, managed care experts, parents, and individuals with PWS were conducted from July 1 to December 1, 2016. Review of the literature was used to provide support. Results Data are presented based on consensus from these interviews by specialty focusing on unique aspects of care, research, and management. We have also defined the Center of Excellence beyond the multidisciplinary clinic. Conclusion Establishment of clinics motivates collaboration to provide evidence‐based new standards of care, increases the knowledge base including through randomized controlled trials, and offers an additional resource for the community. They have a role in global telemedicine, including to rural areas with few resources, and create opportunities for clinical work to inform basic and translational research. As a care team, we are currently charged with understanding the molecular basis of PWS beyond the known genetic cause; developing appropriate clinical outcome measures and biomarkers; bringing new therapies to change the natural history of disease; improving daily patient struggles, access to care, and caregiver burden; and decreasing healthcare load. Based on experience to date with a PWS multidisciplinary clinic, we propose a design for this approach and emphasize the development of “Centers of Excellence.” We highlight the dearth of evidence for management approaches creating huge gaps in care practices as a means to illustrate the importance of the collaborative environment and translational approaches.

show abstract

Improving medication safety and diabetes management in Hong Kong: a multidisciplinary approach

Cited by 15 publications

References 32 publications

Magnitude and determinants of drug therapy problems among type 2 diabetes mellitus patients with hypertension in Ethiopia

Magnitude and determinants of drug therapy problems among type 2 diabetes mellitus patients with hypertension in Ethiopia

Effectiveness of a pharmacist-led medication review programme on medication appropriateness and hospital readmissions among geriatric in-patients in Hong Kong

A multidisciplinary approach to the clinical management of Prader–Willi syndrome

Contact Info

Product

Resources

About